Article
Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD.
Frontiers in immunology - 1 Jan 2022
Illig David, Kotlarz Daniel
Abstract excerpt
Inflammatory bowel disease (IBD) is a multifactorial disorder triggered by imbalances of the microbiome and immune dysregulations in genetically susceptible individuals. Several mouse and human studies have demonstrated that multimeric inflammasomes are critical regulators of host defense and gut homeostasis by modulating immune responses to pathogen- or damage-associated molecular patterns. In the context of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
